Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magic bullets for protein kinases.

A C Bishop1, O Buzko, K M Shokat

  • 1Skaggs Institute for Chemical Biology, Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Trends in Cell Biology
|April 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.

Oncogene·2013
Same author

PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.

Leukemia·2008
Same author

Chemically targeting the PI3K family.

Biochemical Society transactions·2007
Same author

Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.

Proceedings of the National Academy of Sciences of the United States of America·2004
Same author

Phage-display evolution of tyrosine kinases with altered nucleotide specificity.

Biopolymers·2002
Same author

Recent advances in chemical approaches to the study of biological systems.

Annual review of cell and developmental biology·2001
Same journal

Horizontal transfer of mitochondria in cancer: The physiology reborn in disease?

Trends in cell biology·2026
Same journal

Spindle errors: A stress test for epithelial robustness.

Trends in cell biology·2026
Same journal

Multicellular ecosystems: Linking cellular diversity to tissue function and disease.

Trends in cell biology·2026
Same journal

Orchestrating the signaling-bias at the protease-activated receptor, PAR1.

Trends in cell biology·2026
Same journal

Crashing by design: Utilizing DNA damage for MCC differentiation.

Trends in cell biology·2026
Same journal

The value of a shared lab: Our insights.

Trends in cell biology·2026
See all related articles

A new chemical-genetic method enables the creation of specific protein kinase inhibitors. This approach uses a silent mutation to sensitize kinases to drugs, allowing targeted inhibition of mutant kinases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Chemical Biology

Background:

  • Protein kinases are crucial regulators of cellular processes.
  • Developing specific inhibitors for kinases is vital for research and therapeutics.
  • Existing methods may lack specificity or broad applicability.

Purpose of the Study:

  • To develop a novel chemical-genetic strategy for generating target-specific protein kinase inhibitors.
  • To demonstrate the versatility of this approach across different kinase families.
  • To enable the creation and analysis of conditional kinase alleles in vivo.

Main Methods:

  • Utilizing a functionally silent active-site mutation to sensitize target kinases.
  • Designing small molecules that inhibit sensitized kinases but not wild-type versions.

Related Experiment Videos

  • Applying the drug-sensitization approach to various kinase families, including tyrosine and serine/threonine kinases.

    • Main Results:

    • Successfully generated specific inhibitors for mutant Src-family, Abl-family, cyclin-dependent, mitogen-activated, p21-activated, and Ca(2+)/calmodulin-dependent kinases.
    • Demonstrated inhibitor specificity for sensitized kinases in cellular contexts with inactivated wild-type kinases.
    • Systematically generated and analyzed conditional alleles of yeast protein kinases in vivo.

    Conclusions:

    • The developed chemical-genetic method is effective for generating target-specific protein kinase inhibitors.
    • The drug-sensitization approach is broadly applicable to diverse kinase families.
    • This strategy provides a powerful tool for studying kinase function and developing targeted therapies.